BACKGROUND: Follow-up care is critical for childhood cancer survivors (CCS), who are at high risk for comorbidities and late effects of cancer treatments. Understanding the factors associated with maintaining follow-up care is needed, especially for Hispanic CCS, who have been under-represented in previous studies. METHODS: Risk factors and protective factors for receiving cancer-related follow-up care were examined among 193 Los Angeles County CCS diagnosed between 2000 and 2007 (54% Hispanic; mean ± standard deviation age, 19.9 ± 2.8 years; age at diagnosis, 12.1 ± 3.0 years; time since diagnosis, 7.8 ± 2.0 years). Self-report surveys were used to assess follow-up care, insurance status, demographics, clinical factors, and psychosocial risk (eg, depression) and protective (eg, self-efficacy [SE]) factors. Multivariable logistic regression was used to identify factors associated with the previous receipt of cancer-related follow-up care (in prior 2 years) and the intent to seek future cancer-related follow-up care. RESULTS: Seventy-three percent of CCS reported a cancer follow-up visit in the previous 2 years, which was positively associated (P < .05) with having health insurance, white ethnicity (vs Hispanic), younger age, and greater treatment intensity. Sixty-nine percent reported an intent to receive follow-up care in the next 2 years, which was positively associated (P < .05) with having health insurance and greater SE. CONCLUSIONS: Hispanics and older CCS were more likely to lack previous follow-up care. Because health insurance was strongly associated with both previous follow-up care and the intent to seek care, the current results indicate that recent changes in health coverage may improve follow-up among CCS. Interventions targeting improved SE may help increase intent to receive follow-up care for this population.
BACKGROUND: Follow-up care is critical for childhood cancer survivors (CCS), who are at high risk for comorbidities and late effects of cancer treatments. Understanding the factors associated with maintaining follow-up care is needed, especially for Hispanic CCS, who have been under-represented in previous studies. METHODS: Risk factors and protective factors for receiving cancer-related follow-up care were examined among 193 Los Angeles County CCS diagnosed between 2000 and 2007 (54% Hispanic; mean ± standard deviation age, 19.9 ± 2.8 years; age at diagnosis, 12.1 ± 3.0 years; time since diagnosis, 7.8 ± 2.0 years). Self-report surveys were used to assess follow-up care, insurance status, demographics, clinical factors, and psychosocial risk (eg, depression) and protective (eg, self-efficacy [SE]) factors. Multivariable logistic regression was used to identify factors associated with the previous receipt of cancer-related follow-up care (in prior 2 years) and the intent to seek future cancer-related follow-up care. RESULTS: Seventy-three percent of CCS reported a cancer follow-up visit in the previous 2 years, which was positively associated (P < .05) with having health insurance, white ethnicity (vs Hispanic), younger age, and greater treatment intensity. Sixty-nine percent reported an intent to receive follow-up care in the next 2 years, which was positively associated (P < .05) with having health insurance and greater SE. CONCLUSIONS: Hispanics and older CCS were more likely to lack previous follow-up care. Because health insurance was strongly associated with both previous follow-up care and the intent to seek care, the current results indicate that recent changes in health coverage may improve follow-up among CCS. Interventions targeting improved SE may help increase intent to receive follow-up care for this population.
Authors: Cheryl L Cox; Liang Zhu; Lorna Finnegan; Brenda D Steen; Melissa M Hudson; Leslie L Robison; Kevin C Oeffinger Journal: Psychooncology Date: 2011-03-06 Impact factor: 3.894
Authors: Jason A Craw; Lytt I Gardner; Gary Marks; Richard C Rapp; Jeff Bosshart; Wayne A Duffus; Amber Rossman; Susan L Coughlin; DeAnn Gruber; Lauretta A Safford; Jon Overton; Karla Schmitt Journal: J Acquir Immune Defic Syndr Date: 2008-04-15 Impact factor: 3.731
Authors: Paul C Nathan; Jennifer S Ford; Tara O Henderson; Melissa M Hudson; Karen M Emmons; Jacqueline N Casillas; E Anne Lown; Kirsten K Ness; Kevin C Oeffinger Journal: J Clin Oncol Date: 2009-03-02 Impact factor: 44.544
Authors: Paul C Nathan; Mark L Greenberg; Kirsten K Ness; Melissa M Hudson; Ann C Mertens; Martin C Mahoney; James G Gurney; Sarah S Donaldson; Wendy M Leisenring; Leslie L Robison; Kevin C Oeffinger Journal: J Clin Oncol Date: 2008-09-20 Impact factor: 50.717
Authors: Linda C Harlan; Charles F Lynch; Theresa H M Keegan; Ann S Hamilton; Xiao-Cheng Wu; Ikuko Kato; Michele M West; Rosemary D Cress; Stephen M Schwartz; Ashley W Smith; Dennis Deapen; Sonja M Stringer; Arnold L Potosky Journal: J Cancer Surviv Date: 2011-01-28 Impact factor: 4.442
Authors: Joel Milam; Rhona Slaughter; Kathleen Meeske; Anamara Ritt-Olson; Sandra Sherman-Bien; David R Freyer; Aura Kuperberg; Ann S Hamilton Journal: Psychooncology Date: 2015-08-27 Impact factor: 3.894
Authors: Joel Milam; Rhona Slaughter; Jessica L Tobin; Jennifer B Unger; Anamara Ritt-Olson; David R Freyer; Daniel Soto; Ann S Hamilton Journal: J Adolesc Health Date: 2018-07 Impact factor: 5.012
Authors: Kimberly A Miller; Cynthia N Ramirez; Katherine Y Wojcik; Anamara Ritt-Olson; Lourdes Baezconde-Garbanati; Stefanie M Thomas; David R Freyer; Ann S Hamilton; Joel E Milam Journal: Support Care Cancer Date: 2017-11-09 Impact factor: 3.603
Authors: Jessica Tobin; Kimberly A Miller; Lourdes Baezconde-Garbanati; Jennifer B Unger; Ann S Hamilton; Joel E Milam Journal: Ethn Dis Date: 2018-02-01 Impact factor: 1.847
Authors: Kimberly A Miller; Katherine Y Wojcik; Cynthia N Ramirez; Anamara Ritt-Olson; David R Freyer; Ann S Hamilton; Joel E Milam Journal: Pediatr Blood Cancer Date: 2016-08-27 Impact factor: 3.167
Authors: Smita Bhatia; Todd M Gibson; Kirsten K Ness; Qi Liu; Kevin C Oeffinger; Kevin R Krull; Paul C Nathan; Joseph P Neglia; Wendy Leisenring; Yutaka Yasui; Leslie L Robison; Gregory T Armstrong Journal: Cancer Date: 2016-06-02 Impact factor: 6.860
Authors: E Anne Lown; Farya Phillips; Lisa A Schwartz; Abby R Rosenberg; Barbara Jones Journal: Pediatr Blood Cancer Date: 2015-12 Impact factor: 3.167